Cell Signaling Technology

Product Pathways - MAPK Signaling

p44/42 MAP Kinase Assay Kit (Nonradioactive) #9800

Kit Includes Quantity Source
Immobilized Phospho-p44/42 MAPK (Thr202/Tyr204) Mouse mAb # 9109 600 microliters Mouse
Phospho-Elk-1 (Ser383) Antibody # 9181 100 microliters Rabbit
Elk-1 Fusion Protein # 9184 80 micrograms
Kinase Buffer (10X) # 9802 15 milliliters
Cell Lysis Buffer (10X) # 9803 15 milliliters
ATP (10 mM) # 9804 50 microliters
Anti-rabbit IgG, HRP-linked Antibody # 7074 50 microliters Goat
Anti-biotin, HRP-linked Antibody # 7075 100 microliters Goat
Biotinylated Protein Ladder Detection Pack # 7727 100 microliters
20X LumiGLO® Reagent and 20X Peroxide # 7003 5 milliliters each
Active p42 MAP Kinase (10 ng/?l) 10 microliters

Molecular Weight

45

Reactivity

H M R

Reactivity Key:  H=Human  M=Mouse  R=Rat

Description

Nonradioactive p44/42 MAP Kinase Assay Kit provides all the reagents necessary for measuring p44/42 MAP kinase activity in the cell. Immobilized Phospho-p44/42 MAPK (Thr202/Tyr204) mAb is used to immunoprecipitate active p44/42 MAP kinase from cell extracts, then an in vitro kinase assay is performed using Elk-1 protein as a substrate. Elk-1 phosphorylation is then detected by Western blotting using Phospho-Elk-1 (Ser383) Antibody.Improvements Over Conventional Assays:Improved sensitivity without radioactivityPhospho-specific antibodies allow site-specific analysisDramatically increased signal to noise ratio over conventional IP/kinase assaysLow background activityIncludes complete system to assay kinase activity

Western Blotting

Western Blotting

p44/42 MAP Kinase-induced phosphorylation of Elk-1 was measured by quantitative immunoblotting with Phospho-Elk-1 Antibody (A) and compared to direct measurement of phosphate incorporation using [γ-32P]-ATP (B). (Note exposure time difference).

Improvements Over Conventional Assays

No Radioactivity
Improved sensitivity without radioactivity.
Specificity
Phospho-specific antibodies allow site-specific analysis.
Signal to Noise
Dramatically increased signal to noise ratio over conventional IP/kinase assays.
Low Background Activity
Complete System
Includes everything needed to assay kinase activity.

Background

Mitogen-activated protein kinases (MAPKs) are a widely conserved family of serine/threonine protein kinases involved in many cellular programs such as cell proliferation, differentiation, motility, and death. The p44/42 MAPK (ERK1/2) signaling pathway can be activated in response to a diverse range of extracellular stimuli including mitogens, growth factors, and cytokines (1-3) and is an important target in the diagnosis and treatment of cancer (4). Upon stimulation, a sequential three-part protein kinase cascade is initiated, consisting of a MAP kinase kinase kinase (MAPKKK), a MAP kinase kinase (MAPKK), and a MAP kinase. While multiple ERK1/2 MAP3Ks have been identified, including the Raf family, Mos, and Tpl2/Cot, MEK1 and MEK2 are the primary MAPKKs in this pathway (5,6). MEK1 and MEK2 activate ERK1/p44 and ERK2/p42 through phosphorylation of activation loop residues Thr202/Tyr204 and Thr185/Tyr187, respectively. Several downstream targets of ERK1/2 have been identified, including p90RSK (7) and the transcription factor Elk-1 (8,9). ERK1/2 are negatively regulated by a family of dual-specificity (Thr/Tyr) MAPK phosphatases, known as DUSPs or MKPs (10), along with MEK inhibitors such as U0126 and PD98059.

  1. Roux, P.P. and Blenis, J. (2004) Microbiol Mol Biol Rev 68, 320-44.
  2. Baccarini, M. (2005) FEBS Lett 579, 3271-7.
  3. Meloche, S. and Pouyssegur, J. (2007) Oncogene 26, 3227-39.
  4. Roberts, P.J. and Der, C.J. (2007) Oncogene 26, 3291-310.
  5. Rubinfeld, H. and Seger, R. (2005) Mol Biotechnol 31, 151-74.
  6. Murphy, L.O. and Blenis, J. (2006) Trends Biochem Sci 31, 268-75.
  7. Dalby, K.N. et al. (1998) J Biol Chem 273, 1496-505.
  8. Marais, R. et al. (1993) Cell 73, 381-93.
  9. Kortenjann, M. et al. (1994) Mol Cell Biol 14, 4815-24.
  10. Owens, D.M. and Keyse, S.M. (2007) Oncogene 26, 3203-13.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products

Product Pathways

Drug Discovery Tools

Featured Technologies

Protein Classes